A History of Screening for Natural Products to Fight Cancer

In the middle of the 20th century, the National Cancer Institute began testing plant extracts for chemotherapeutic potential—helping to discover some drugs still in use today.

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

SCREEN TIME: By 1950, Jonathan Hartwell (right) and his team were regularly screening plant extracts sent to the National Cancer Institute by botanists. Initially, the NCI investigators tested the crude extracts in mice harboring natural mouse tumors. Over the next few decades, their methods evolved with the technology to include human cancer cell lines and immunosuppressed mice that carried human cancers. (Upon request from The Scientist, the NCI tried to identify the pharmacy technician in the photo, but could not find her name.)FLICKR, NATIONAL CANCER INSTITUTE

Update (June 13): Upon asking readers on social media for help in identifying the mystery researcher in the photo, The Scientist has identified her as biochemist Sylvy Kornberg. Read about her life.

Organic chemist Jonathan Hartwell joined the National Cancer Institute (NCI) to head up a natural products division in 1938, not long after the agency was founded. He’d read plenty of folklore about how plants had healed various ailments over the centuries, and wanted to identify compounds that might have chemotherapeutic potential. So he put out a call to researchers to collect plants from all over the world and send him extracts for testing.

In 1955, the NCI set up the Cancer Chemotherapy National Service Center to investigate all manner of compounds with potential ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Published In

April 2017

Targeting Tumors

Precision aim to spare healthy cells

Share
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel